FSANZ calls for comment on infant formula method
Food Standards Australia New Zealand (FSANZ) is requesting comments on an application it has received to allow a new method of producing an already-used oligosaccharide, 2′fucosyllactose (or 2ʹ-FL for simplicity).
The oligosaccharide is already added to infant formula but the new method would use a different method of production that involves a genetically modified Escherichia coli strain. The resulting 2ʹ-FL is identical to the oligosaccharide that is produced in human milk and the E. coli strain that is being used is also permitted for production of other substances. FSANZ analyses showed no safety concerns or published health issues with the substance.
2ʹ-FL produced by a strain of genetically modified bacteria is already permitted for use and another application for a different strain is currently undergoing assessment.
The submissions for the application will be closed from 6 pm (Canberra Time), 31 January 2022.
To submit a comment regarding this application, this is the page to use. To read more about the application and method, peruse this page and its links.
Maxum Foods appoints its first CEO
Maxum Foods, a dairy ingredients supplier for food manufacturers across Australia and NZ, has...
Suntory Oceania’s $3bn beverage business launched in Qld
Now claimed as the region’s fourth largest multi-beverage group, the official launch...
Heat and Control showcases sustainable food processing solutions
At its FoodTech Forum 2025 hosted in the Netherlands, Heat and Control showcased the latest...